Choi (Jaehyuk) Lab
Pioneering therapies for immune-related diseases.
The goal of the Choi Lab is to develop novel immunotherapies. To accomplish this, we first utilize high-dimensional approaches on human disease samples. This approach identifies targetable disease-promoting molecular defects in immune cells. Then, we utiize engineering approaches to reverse molecular changes.
Dr. Choi the inaugural Director of the new Center for Cellular Therapies and Cancer Immunology in the Harold C. Simmons Comprehensive Cancer Center. He also serves as Vice Chair for Translational Research and Innovation in the Department of Dermatology and holds the Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology. After completing undergraduate studies in biochemistry at Harvard University, Dr. Choi earned his medical degree and Ph.D. in immunobiology from Yale University School of Medicine. He has been recognized with a number of awards, including the Damon Runyon Clinical Investigator Award (2016), the NIH Director’s New Innovator Award (2017), and the Mark Foundation Emerging Leader Award (2022).